These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37951044)

  • 1. Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies.
    Papa A; Santini P; De Lucia SS; Maresca R; Porfidia A; Pignatelli P; Gasbarrini A; Violi F; Pola R
    Thromb Res; 2023 Dec; 232():77-88. PubMed ID: 37951044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis.
    Violi F; Pignatelli P; Castellani V; Carnevale R; Cammisotto V
    Blood Rev; 2023 Jan; 57():100998. PubMed ID: 35985881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
    Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
    Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
    Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
    Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut dysbiosis induces the development of mastitis through a reduction in host anti-inflammatory enzyme activity by endotoxemia.
    Zhao C; Hu X; Bao L; Wu K; Zhao Y; Xiang K; Li S; Wang Y; Qiu M; Feng L; Meng X; Zhang N; Fu Y
    Microbiome; 2022 Dec; 10(1):205. PubMed ID: 36451232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium?
    Violi F; Castellani V; Menichelli D; Pignatelli P; Pastori D
    Am Heart J; 2023 Oct; 264():40-48. PubMed ID: 37301317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
    Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
    Front Immunol; 2020; 11():574500. PubMed ID: 33042155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease.
    Kul S; Caliskan Z; Guvenc TS; Celik FB; Sarmis A; Atici A; Konal O; Akıl M; Cumen AS; Bilgic NM; Yilmaz Y; Caliskan M
    Microvasc Res; 2023 Mar; 146():104458. PubMed ID: 36471530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.
    Iyer N; Corr SC
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis.
    Luchetti MM; Ciccia F; Avellini C; Benfaremo D; Rizzo A; Spadoni T; Svegliati S; Marzioni D; Santinelli A; Costantini A; Viola N; Berretta A; Ciferri M; Mattioli Belmonte Cima M; Mosca P; Benedetti A; Gabrielli A
    Rheumatology (Oxford); 2021 Jan; 60(1):92-102. PubMed ID: 32442267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
    Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
    Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
    Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.